Physiomics is a data-driven consultancy accelerating and de-risking the development of new drugs, providing Model-Informed Drug Development (MIDD), Biostatistics, Statistical Programming and Bioinformatics solutions. We support drug developers, from emerging Biotech to Top Tier Pharma, as well as Research Institutes, throughout the drug development continuum - from dicovery through to the clinic.